ArtJen Announces Updated Affiliate Program For Our Fat Fighter

Share Article

ArtJen Complexus Holdings Corp. is pleased to announce that as part of its continuing effort to make its Fat Fighter, FBCx, more readily available for the war on obesity it has updated and improved its Web Affiliate program. The updated program is user friendly and reimburses members a fixed rate per order with no ceiling on their earnings.

Dubbed the “Fat Fighter” in recent coverage by the Detroit Fox Network affiliate and said to be showing “huge potential” by Canadian print media, ArtJen Complexus Holdings Corp. is pleased to announce that as part of its continuing effort to make our Fat Fighter, FBCx, more readily available for the war on obesity it has updated and improved its Web Affiliate program. The updated program is user-friendly and reimburses members a fixed rate per order with no ceiling on their earnings. Customers’ orders are tracked and affiliates are also compensated for repeat orders. ArtJen can be found on the web at http://www.artjen.net or by telephone at 1-877-4-ARTJEN.

FBCx, the newest weapon in the war on obesity is also available in all SAV-ON Drug stores in Southeastern Michigan as well as Dr. Grunberger’s Diabetes Institute at 43494 Woodward, Bloomfield Hills, MI (248-335-7740). A complete list of both US and Canadian stores can be found at http://www.artjen.net click on “Shop In Person” for details.

George Grunberger, M.D., K-L Catherine Jen, Ph.D. and Joseph Artiss, Ph.D. recently presented the findings of their clinical trial on volunteers with type 2 diabetes at both the June meeting of the American Diabetes Association and the October meeting of the North American Association for the Study of Obesity. Important conclusions to the Clinical Trial include:

  • FBCx is effective in reducing and/or maintaining body weight in patients with type 2 diabetes.
  • FBCx is effective in reducing blood cholesterol and triglyceride levels in patients with hyperlipidemia.
  • FBCx can easily be incorporated into a diabetes management regimen.
  • FBCx was shown to bind more than 9 times its own weight in dietary fat in human volunteers.
  • FBCx is effective for weight management.

Dr Grunberger, of the renowned Grunberger Diabetes Institute states that: “About 90 % of patients with type 2 diabetes are obese and that obesity is the number 2 preventable cause of death in the U.S.” Before FBCx, “There was no known effective way to keep weight off.” Said Dr Grunberger “This discovery, which can help shed pounds or prevent weight gain, is real progress.” Dr Jen said, “Unlike claims made by others, this product actually works.”

The important results of this clinical trial could change dietary management in patients with type 2 diabetes. Subjects in preclinical trials, including non-diabetic patients showed dramatic and consistent weight loss. Employing a natural fiber, each 1 gram tablet binds more than 9 grams of dietary fat effectively preventing the fat from being absorbed by the body.

Taking the recommended 2 tablets per typical North American meal results in a weight loss of 1 to 1.5 pounds per week. The product is now available under the FBCx trademark for Fat Binding Complexer. A US patent has been awarded to the ArtJen Company for FBCx; worldwide patents are pending.

For further information contact Dr. Joe Artiss through ArtJen’s toll free number 1-877-4-ARTJEN.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website